Gibbs Wealth Management Grows Stock Holdings in Tenet Healthcare Corporation $THC

Gibbs Wealth Management raised its holdings in Tenet Healthcare Corporation (NYSE:THC) by 81.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 6,472 shares of the company’s stock after acquiring an additional 2,908 shares during the period. Gibbs Wealth Management’s holdings in Tenet Healthcare were worth $1,221,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Triumph Capital Management acquired a new position in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management acquired a new stake in shares of Tenet Healthcare in the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare during the fourth quarter worth approximately $29,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. Finally, Meeder Asset Management Inc. grew its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Analyst Ratings Changes

THC has been the topic of several research reports. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research report on Friday, May 1st. Wall Street Zen lowered Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. Barclays lifted their price objective on Tenet Healthcare from $238.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, July 8th. Wells Fargo & Company increased their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average target price of $244.84.

Tenet Healthcare Trading Up 2.3%

NYSE THC opened at $199.85 on Friday. The stock has a market cap of $17.22 billion, a P/E ratio of 10.39, a PEG ratio of 1.62 and a beta of 1.27. The company’s fifty day simple moving average is $184.43 and its 200-day simple moving average is $197.37. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm had revenue of $5.63 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.02 EPS. Equities research analysts predict that Tenet Healthcare Corporation will post 17.5 EPS for the current fiscal year.

Insider Activity

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Nadja West sold 3,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.97% of the company’s stock.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported second-quarter EPS of $6.12, well above consensus, and revenue of $5.63 billion, also topping estimates, signaling stronger-than-expected operating performance. Article Title
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above Wall Street expectations, which suggests management sees continued earnings strength ahead. Article Title
• Positive Sentiment: Investor optimism was also supported by Tenet’s improving credit profile and recent analyst sentiment, which had already set up the stock for a strong move into earnings. Article Title
• Neutral Sentiment: Analysts continue to view the stock favorably overall, with a consensus “Moderate Buy” rating, though some recent commentary has been more cautious on valuation. Article Title

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.